Search Results - Daniel Castellano

Refine Results
  1. 1
    Long‐term impact of obesity: Unraveling adipose epigenetic memory

    Long‐term impact of obesity: Unraveling adipose epigenetic memory by Laura C. Hinte, Daniel Castellano‐Castillo, Ferdinand von Meyenn

    Published 2025
    Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain

    The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain by Rhys Pockett, Daniel Castellano, Phil McEwan, Alan Oglesby, BL Barber, Karen Chung

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Caracterización de pacientes con miedo al Odontólogo

    Caracterización de pacientes con miedo al Odontólogo by José Manuel Valdés Reyes, Daniel Castellano-Prada, Yamile El-Ghannam-Ruisánchez, Larry Angel Delgado Martín

    Published 2015
    Artigo
    Save to List
    Saved in:
  4. 4
    The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab

    The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab by Daniel Castellano, Juan Manuel Sepúlveda-Sánchez, Ignacio Escobar, A. Rodrı́guez-Antolı́n, Anna Sundlöv, H. Cortés-Funes

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Cabozantinib for the treatment of solid tumors: a systematic review

    Cabozantinib for the treatment of solid tumors: a systematic review by Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

    Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study by Daniel Castellano, Emilio Bajetta, Ashok Panneerselvam, Stephen Saletan, Walter Kocha, Thomas M. O’Dorisio, Lowell Anthony, Timothy J. Hobday

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Adipose tissue inflammation and VDR expression and methylation in colorectal cancer

    Adipose tissue inflammation and VDR expression and methylation in colorectal cancer by Daniel Castellano‐Castillo, Sonsoles Morcillo, Mercedes Clemente‐Postigo, Ana B. Crujeiras, José Carlos Fernández‐García, Esperanza Torres, Francisco J. Tinahones, Manuel Macías‐González

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR

    Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR by Daniel Castellano‐Castillo, Pierre‐Damien Denechaud, Lluís Fajas, Isabel Moreno‐Indias, Wilfredo Oliva‐Olivera, Francisco J. Tinahones, María Isabel Queipo‐Ortuño, Fernando Cardona

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

    The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials by Alberto Carretero-González, David Lora, Isabel Martín Sobrino, Irene Sáez Sanz, María T. Bourlon, Urbano Anido Herranz, Nieves Martínez Chanzá, Daniel Castellano, Guillermo de Velasco

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials

    Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials by Alberto Carretero-González, David Lora, Ismael Ghanem, Jon Zugazagoitia, Daniel Castellano, Juan Manuel Sepúlveda-Sánchez, José A. López-Martín, Luis Paz‐Ares, Guillermo de Velasco

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

    Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma by Eric Angevin, José A. López-Martín, Chia‐Chi Lin, Jürgen E. Gschwend, Andrea Harzstark, Daniel Castellano, Jean‐Charles Soria, Paramita Sen, Julie Chang, Michael Shi, Andrea Kay, Bernard Escudier

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus

    Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus by Lidia Sánchez‐Alcoholado, Daniel Castellano‐Castillo, Laura Jordán-Martínez, Isabel Moreno‐Indias, Pilar Cardila-Cruz, Daniel Elena, Antonio J. Muñoz-García, María Isabel Queipo‐Ortuño, Manuel F. Jiménez‐Navarro

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study

    Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study by Isabel Leiva‐Gea, Lidia Sánchez‐Alcoholado, Beatriz Martín-Tejedor, Daniel Castellano‐Castillo, Isabel Moreno‐Indias, Antonio Urda-Cardona, Francisco J. Tinahones, José Carlos Fernández‐García, María Isabel Queipo‐Ortuño

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Inflammatory Candidate Genes and Metabolic Variables

    Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Infla... by Daniel Castellano‐Castillo, Isabel Moreno‐Indias, Lidia Sánchez‐Alcoholado, Bruno Ramos‐Molina, Juan Alcaide‐Torres, Sonsoles Morcillo, Luís Ocaña-Wilhelmi, Francisco J. Tinahones, María Isabel Queipo‐Ortuño, Fernando Cardona

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

    Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma by Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde, Yohann Loriot, Ignacio Durán, Jae‐Lyun Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Chunzhang Wu, Mary S. Campbell, Maria Matsangou, Daniel P. Petrylak

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity

    Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enha... by Joaquim Bellmunt, J.L. González-Larriba, Celia Prior, Pablo Maroto, Joan Carles, Daniel Castellano, Begoña Mellado, Enrique Gallardo, Jose Luis Pérez‐Gracia, Guadalupe Aguilar, Xavier Villanueva, Joan Albanell, Alfonso Calvo

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

    Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer by Bernard Escudier, Viktor Grünwald, Alain Ravaud, Yen‐Chuan Ou, Daniel Castellano, Chia‐Chi Lin, Jürgen E. Gschwend, Andrea Harzstark, Sarah L Beall, Nicoletta Pirotta, Matthew Squires, Michael Shi, Eric Angevin

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Type 2 Diabetes Is Associated with a Different Pattern of Serum Polyamines: A Case–Control Study from the PREDIMED-Plus Trial

    Type 2 Diabetes Is Associated with a Different Pattern of Serum Polyamines: A Case–Control Study from the PREDIMED-Plus Trial by José Carlos Fernández‐García, Antoni Delpino-Rius, Iris Samarra, Daniel Castellano‐Castillo, Araceli Muñoz‐Garach, M. Rosa Bernal‐López, María Isabel Queipo‐Ortuño, Fernando Cardona, Bruno Ramos‐Molina, Francisco J. Tinahones

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)

    Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU) by Jonathan E. Rosenberg, Se Hoon Park, Vadim Kozlov, Tu Van Dao, Daniel Castellano, Jian‐Ri Li, Som D. Mukherjee, Kathryn Howells, Hannah Dry, Mark C. Lanasa, Ross Stewart, Dean F. Bajorin

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

    New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors by Aristotelis Bamias, Axel S. Merseburger, Yohann Loriot, Nicholas D. James, Ernest Choy, Daniel Castellano, Fernando López‐Ríos, Fabio Calabrò, Mario W. Kramer, Guillermo de Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N. Sternberg

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: